Emerging evidence has demonstrated the involvement of HuR in the pathogenesis of various liver diseases, including fatty liver diseases, hepatic inflammation, viral hepatitis, liver fibrosis, and liver cancers [20–22, 41]. Here, ELAVL1 is linked to inflammatory response.